Urethral atresia and anhydramnios at 18 weeks of gestation can result in normal development.
Abstract
[INTRODUCTION] Second-trimester anhydramnios is incompatible with survival unless amniotic fluid volume is restored. We describe the long-term outcome of a child with documented anhydramnios at 17 weeks.
[CASE REPORT] A 28-year-old gravida II had anhydramnios at 17 weeks. At 19 weeks, the bladder measured 12 cm, and karyotype was XY. At 21 weeks, a fistula between the bladder and the amniotic space developed. At 36 weeks, a 2800 g boy with prune belly phenotype was delivered. The urachus was patent and drained urine. There was a completely obstructing membrane below the veru montanum and a hypoplastic urethra distal to it. The right kidney had no function and the left had grade V reflux. A P.A.D.U.A. (progressive augmentation by dilatating the urethra anterior) procedure was performed and the urachal fistula closed. At 6 months of age abdominoplasty, bilateral orchidopexy, right nephrectomy and left to right transuretero-ureterostomy were performed. At age 30 months he was toilet trained, with creatinine 0.5 mg/dl and normal growth. At 10 years of age he continues to be continent, with serum creatinine 0.9 mg/dl.
[CONCLUSION] Resolution of anhydramnios at 21 weeks of gestation can result in normal pulmonary function and acceptable renal and bladder function in childhood. Efforts to develop effective methods of fetal bladder decompression should continue.
[CASE REPORT] A 28-year-old gravida II had anhydramnios at 17 weeks. At 19 weeks, the bladder measured 12 cm, and karyotype was XY. At 21 weeks, a fistula between the bladder and the amniotic space developed. At 36 weeks, a 2800 g boy with prune belly phenotype was delivered. The urachus was patent and drained urine. There was a completely obstructing membrane below the veru montanum and a hypoplastic urethra distal to it. The right kidney had no function and the left had grade V reflux. A P.A.D.U.A. (progressive augmentation by dilatating the urethra anterior) procedure was performed and the urachal fistula closed. At 6 months of age abdominoplasty, bilateral orchidopexy, right nephrectomy and left to right transuretero-ureterostomy were performed. At age 30 months he was toilet trained, with creatinine 0.5 mg/dl and normal growth. At 10 years of age he continues to be continent, with serum creatinine 0.9 mg/dl.
[CONCLUSION] Resolution of anhydramnios at 21 weeks of gestation can result in normal pulmonary function and acceptable renal and bladder function in childhood. Efforts to develop effective methods of fetal bladder decompression should continue.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | abdominoplasty
|
복부성형술 | dict | 1 | |
| 해부 | bladder
|
scispacy | 1 | ||
| 해부 | urachus
|
scispacy | 1 | ||
| 해부 | membrane
|
scispacy | 1 | ||
| 해부 | urethra
|
scispacy | 1 | ||
| 해부 | kidney
|
scispacy | 1 | ||
| 해부 | bilateral
|
scispacy | 1 | ||
| 해부 | serum creatinine
|
scispacy | 1 | ||
| 해부 | pulmonary
|
scispacy | 1 | ||
| 합병증 | Urethral atresia
|
scispacy | 1 | ||
| 합병증 | amniotic fluid
|
scispacy | 1 | ||
| 합병증 | urachal fistula
|
scispacy | 1 | ||
| 약물 | creatinine
|
C0010294
creatinine
|
scispacy | 1 | |
| 약물 | [INTRODUCTION] Second-trimester
|
scispacy | 1 | ||
| 질환 | Urethral atresia
|
C0345345
Atresia of urethra
|
scispacy | 1 | |
| 질환 | anhydramnios
|
C0730379
Anhydramnios
|
scispacy | 1 | |
| 질환 | fistula
|
C0016169
pathologic fistula
|
scispacy | 1 | |
| 질환 | urachal fistula
|
C0345344
Urachal fistula
|
scispacy | 1 | |
| 질환 | renal
|
scispacy | 1 | ||
| 기타 | urethra anterior
|
scispacy | 1 |
MeSH Terms
Adult; Diagnosis, Differential; Disease Progression; Endoscopy; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications; Prune Belly Syndrome; Recovery of Function; Time Factors; Ultrasonography, Prenatal; Urethra; Urethral Diseases; Urologic Surgical Procedures, Male
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Case report of a rare soft tissue tuberculosis in a patient undergoing lipoabdominoplasty.
- What is the potential role of the nonopioid suzetrigine in pain management?
- Ex Vivo and In Vivo Histological Evaluation of a 3-μm Wavelength, 40-μm Spot Size Fractional Laser System for Dermatology.
- Correspondence on "Lymphatic pathway remodeling in the supraumbilical region after abdominoplasty: A prospective cohort study".
- Sculpting Success-The TULUANHA: Modified TULUA Lipo-Abdominoplasty in Post-Bariatric Body Contouring.